Torrent Total Stockholder Equity vs Total Current Liabilities Analysis

TORNTPHARM

3,031 7.75 0.26%

Torrent Pharmaceuticals financial indicator trend analysis is much more than just breaking down Torrent Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Torrent Pharmaceuticals is a good investment. Please check the relationship between Torrent Pharmaceuticals Total Stockholder Equity and its Total Current Liabilities accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Torrent Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Total Stockholder Equity vs Total Current Liabilities

Total Stockholder Equity vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Torrent Pharmaceuticals Total Stockholder Equity account and Total Current Liabilities. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Torrent Pharmaceuticals' Total Stockholder Equity and Total Current Liabilities is 0.95. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Torrent Pharmaceuticals Limited, assuming nothing else is changed. The correlation between historical values of Torrent Pharmaceuticals' Total Stockholder Equity and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Torrent Pharmaceuticals Limited are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Total Stockholder Equity i.e., Torrent Pharmaceuticals' Total Stockholder Equity and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.95

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Total Current Liabilities

Total Current Liabilities is an item on Torrent Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Torrent Pharmaceuticals Limited are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most indicators from Torrent Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Torrent Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Torrent Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

The current Selling General Administrative is estimated to decrease to about 4.4 B. The current Tax Provision is estimated to decrease to about 4.1 B

	2022	2023	2024	2025 (projected)
Interest Expense	3.3B	3.5B	4.1B	4.3B
Depreciation And Amortization	7.0B	8.0B	9.1B	9.6B

Interest Expense Depreciation And Amortization

Torrent Pharmaceuticals fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Short Term Investments	Intangible Assets	Current Deferred Revenue	Short Term Debt
Total Assets		0.82	0.63	0.99	0.97	0.99	0.8	0.86	0.42	0.99	0.39	0.36	0.77	0.48	0.81	0.85	0.31	0.26	0.87	0.82	0.81	0.77	0.19	0.97	-0.04	0.86
Short Long Term Debt Total	0.82		0.63	0.83	0.67	0.78	0.99	0.49	0.05	0.84	0.16	0.32	0.77	0.09	0.97	0.85	0.39	-0.18	0.97	0.8	0.42	0.77	0.23	0.88	-0.05	0.9
Other Current Liab	0.63	0.63		0.62	0.57	0.64	0.59	0.42	0.29	0.6	0.34	0.41	0.59	0.28	0.66	0.72	0.46	0.14	0.7	0.72	0.27	0.74	0.17	0.56	-0.16	0.54
Total Current Liabilities	0.99	0.83	0.62		0.95	0.98	0.8	0.85	0.48	0.99	0.34	0.34	0.77	0.48	0.81	0.84	0.29	0.28	0.87	0.81	0.81	0.77	0.13	0.97	-0.11	0.87
Total Stockholder Equity	0.97	0.67	0.57	0.95		0.97	0.65	0.95	0.48	0.95	0.4	0.29	0.7	0.58	0.65	0.82	0.24	0.39	0.75	0.77	0.88	0.68	0.11	0.9	-0.01	0.79
Property Plant And Equipment Net	0.99	0.78	0.64	0.98	0.97		0.75	0.89	0.47	0.98	0.31	0.29	0.75	0.49	0.76	0.87	0.33	0.27	0.84	0.8	0.8	0.74	0.09	0.94	-0.1	0.85
Net Debt	0.8	0.99	0.59	0.8	0.65	0.75		0.45	-0.04	0.82	0.17	0.3	0.73	0.05	0.97	0.81	0.4	-0.24	0.94	0.76	0.38	0.72	0.28	0.87	-0.02	0.87
Retained Earnings	0.86	0.49	0.42	0.85	0.95	0.89	0.45		0.59	0.86	0.31	0.15	0.6	0.66	0.45	0.69	0.07	0.57	0.59	0.62	0.92	0.52	-0.08	0.8	-0.03	0.71
Cash	0.42	0.05	0.29	0.48	0.48	0.47	-0.04	0.59		0.38	0.07	0.17	0.35	0.58	0.04	0.25	-0.15	0.72	0.19	0.3	0.65	0.38	-0.35	0.3	-0.25	0.24
Non Current Assets Total	0.99	0.84	0.6	0.99	0.95	0.98	0.82	0.86	0.38		0.31	0.26	0.73	0.47	0.81	0.84	0.27	0.24	0.87	0.77	0.79	0.72	0.12	0.99	-0.07	0.9
Non Currrent Assets Other	0.39	0.16	0.34	0.34	0.4	0.31	0.17	0.31	0.07	0.31		0.76	0.23	0.36	0.31	0.17	0.21	0.28	0.27	0.43	0.42	0.44	0.78	0.3	0.12	0.04
Cash And Short Term Investments	0.36	0.32	0.41	0.34	0.29	0.29	0.3	0.15	0.17	0.26	0.76		0.4	0.09	0.48	0.31	0.27	-0.01	0.45	0.63	0.27	0.66	0.81	0.25	0.27	0.08
Net Receivables	0.77	0.77	0.59	0.77	0.7	0.75	0.73	0.6	0.35	0.73	0.23	0.4		0.19	0.8	0.87	0.38	0.06	0.87	0.91	0.55	0.9	0.1	0.71	-0.07	0.72
Common Stock Shares Outstanding	0.48	0.09	0.28	0.48	0.58	0.49	0.05	0.66	0.58	0.47	0.36	0.09	0.19		0.07	0.23	-0.17	0.73	0.18	0.23	0.69	0.24	-0.11	0.42	-0.11	0.3
Non Current Liabilities Total	0.81	0.97	0.66	0.81	0.65	0.76	0.97	0.45	0.04	0.81	0.31	0.48	0.8	0.07		0.82	0.41	-0.19	0.97	0.85	0.4	0.84	0.39	0.84	0.02	0.8
Inventory	0.85	0.85	0.72	0.84	0.82	0.87	0.81	0.69	0.25	0.84	0.17	0.31	0.87	0.23	0.82		0.46	-0.01	0.91	0.92	0.55	0.81	0.09	0.81	0.01	0.86
Other Current Assets	0.31	0.39	0.46	0.29	0.24	0.33	0.4	0.07	-0.15	0.27	0.21	0.27	0.38	-0.17	0.41	0.46		-0.48	0.38	0.42	-0.15	0.41	0.32	0.24	-0.17	0.21
Other Stockholder Equity	0.26	-0.18	0.14	0.28	0.39	0.27	-0.24	0.57	0.72	0.24	0.28	-0.01	0.06	0.73	-0.19	-0.01	-0.48		-0.06	0.03	0.65	0.07	-0.3	0.2	-0.13	0.08
Total Liab	0.87	0.97	0.7	0.87	0.75	0.84	0.94	0.59	0.19	0.87	0.27	0.45	0.87	0.18	0.97	0.91	0.38	-0.06		0.91	0.53	0.88	0.25	0.88	-0.04	0.89
Total Current Assets	0.82	0.8	0.72	0.81	0.77	0.8	0.76	0.62	0.3	0.77	0.43	0.63	0.91	0.23	0.85	0.92	0.42	0.03	0.91		0.58	0.93	0.35	0.74	0.07	0.71
Common Stock	0.81	0.42	0.27	0.81	0.88	0.8	0.38	0.92	0.65	0.79	0.42	0.27	0.55	0.69	0.4	0.55	-0.15	0.65	0.53	0.58		0.52	0.01	0.74	-0.01	0.63
Accounts Payable	0.77	0.77	0.74	0.77	0.68	0.74	0.72	0.52	0.38	0.72	0.44	0.66	0.9	0.24	0.84	0.81	0.41	0.07	0.88	0.93	0.52		0.34	0.69	-0.01	0.63
Short Term Investments	0.19	0.23	0.17	0.13	0.11	0.09	0.28	-0.08	-0.35	0.12	0.78	0.81	0.1	-0.11	0.39	0.09	0.32	-0.3	0.25	0.35	0.01	0.34		0.14	0.39	-0.08
Intangible Assets	0.97	0.88	0.56	0.97	0.9	0.94	0.87	0.8	0.3	0.99	0.3	0.25	0.71	0.42	0.84	0.81	0.24	0.2	0.88	0.74	0.74	0.69	0.14		-0.05	0.92
Current Deferred Revenue	-0.04	-0.05	-0.16	-0.11	-0.01	-0.1	-0.02	-0.03	-0.25	-0.07	0.12	0.27	-0.07	-0.11	0.02	0.01	-0.17	-0.13	-0.04	0.07	-0.01	-0.01	0.39	-0.05		-0.15
Short Term Debt	0.86	0.9	0.54	0.87	0.79	0.85	0.87	0.71	0.24	0.9	0.04	0.08	0.72	0.3	0.8	0.86	0.21	0.08	0.89	0.71	0.63	0.63	-0.08	0.92	-0.15

Click cells to compare fundamentals

Torrent Pharmaceuticals Account Relationship Matchups

Torrent Pharmaceuticals fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	140.7B	131.0B	150.1B	150.6B	173.2B	181.9B
Short Long Term Debt Total	48.7B	40.7B	53.7B	40.2B	46.3B	27.1B
Other Current Liab	8.0B	7.4B	1.0B	8.1B	9.4B	4.9B
Total Current Liabilities	48.9B	44.2B	54.5B	54.3B	62.4B	65.5B
Total Stockholder Equity	58.4B	59.5B	62.0B	68.6B	78.8B	82.8B
Property Plant And Equipment Net	36.3B	32.5B	34.6B	35.8B	41.1B	43.2B
Net Debt	43.0B	36.7B	48.6B	31.9B	36.6B	22.3B
Retained Earnings	28.1B	29.2B	33.0B	39.4B	45.3B	47.6B
Cash	5.7B	4.0B	5.1B	8.4B	9.6B	10.1B
Non Current Assets Total	85.5B	79.3B	97.0B	94.5B	108.7B	114.1B
Non Currrent Assets Other	1.1B	3.2B	2.0B	9.0B	10.4B	10.9B
Cash And Short Term Investments	7.4B	5.8B	8.4B	10.0B	11.5B	8.0B
Net Receivables	18.9B	19.2B	19.5B	18.4B	21.2B	12.3B
Liabilities And Stockholders Equity	140.7B	131.0B	150.1B	150.6B	173.2B	181.9B
Non Current Liabilities Total	33.5B	27.3B	33.7B	27.8B	32.0B	20.6B
Inventory	26.8B	24.6B	22.3B	22.8B	26.2B	13.3B
Other Current Assets	21.0B	21.2B	3.0B	4.8B	5.6B	8.4B
Total Liab	82.4B	71.5B	88.1B	82.0B	94.4B	50.0B
Total Current Assets	55.2B	51.6B	53.1B	56.1B	64.5B	35.6B
Accumulated Other Comprehensive Income	29.4B	29.5B	27.3B	27.4B	31.6B	33.1B
Accounts Payable	20.7B	16.7B	16.8B	20.9B	24.0B	15.0B
Short Term Investments	1.7B	1.8B	3.3B	1.7B	1.9B	3.6B
Intangible Assets	39.8B	35.5B	50.9B	45.8B	52.7B	55.3B
Current Deferred Revenue	7.9B	7.3B	8.5B	45M	40.5M	38.5M
Short Term Debt	19.7B	19.5B	28.2B	23.5B	27.1B	15.5B
Other Liab	3.2B	4.3B	3.8B	5.7B	6.6B	4.2B
Net Tangible Assets	(3.6B)	1.1B	15.1B	21.5B	19.3B	20.3B
Other Assets	6.9B	5.3B	6.8B	5.4B	6.3B	3.9B
Long Term Debt	29.4B	21.2B	25.0B	16.0B	18.4B	27.5B
Short Long Term Debt	7.0B	19.0B	28.0B	23.3B	26.8B	16.9B
Property Plant Equipment	35.3B	36.3B	32.5B	34.6B	39.8B	30.0B
Good Will	3.4B	2.6B	3.4B	3.4B	3.9B	3.0B
Long Term Debt Total	33.0B	29.6B	21.6B	25.5B	29.3B	31.8B
Non Current Liabilities Other	50M	40M	20M	10M	11.5M	10.9M
Cash And Equivalents	2.6B	149.3M	228.1M	379.8M	341.8M	324.7M
Net Invested Capital	65.4B	99.7B	115.0B	107.9B	97.1B	81.4B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Other Information on Investing in Torrent Stock

Balance Sheet is a snapshot of the financial position of Torrent Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Torrent Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Torrent Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Torrent currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Torrent Total Stockholder Equity vs Total Current Liabilities Analysis

Total Stockholder Equity vs Total Current Liabilities

Total Stockholder Equity vs Total Current Liabilities Correlation Analysis

Correlation Coefficient

Total Stockholder Equity

Total Current Liabilities

Torrent Pharmaceuticals fundamental ratios Correlations

Torrent Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Torrent Pharmaceuticals fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Torrent Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 0.99	Total Assets
Property Plant And Equipment Net	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Net Debt	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.99	Total Current Liabilities
Intangible Assets	+ 0.99	Non Current Assets Total

Other Stockholder Equity	- 0.48	Other Current Assets
Short Term Investments	- 0.35	Cash
Short Term Investments	- 0.3	Other Stockholder Equity
Current Deferred Revenue	- 0.25	Cash
Other Stockholder Equity	- 0.24	Net Debt
Other Stockholder Equity	- 0.19	Non Current Liabilities Total